Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 6—June 2012
CME ACTIVITY - Research

Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase–producing Enterobacteriaceae and Infection after Liver Transplant, France

Frédéric BertComments to Author , Béatrice Larroque, Catherine Paugam-Burtz, Federica Dondero, François Durand, Estelle Marcon, Jacques Belghiti, Richard Moreau, and Marie-Hélène Nicolas-Chanoine
Author affiliations: Hôpital Beaujon, Clichy, France (F. Bert, B. Larroque, C. Paugam-Burtz, F. Dondero, F. Durand, E. Marcon, J. Belghiti, R. Moreau, M.H. Nicolas-Chanoine); Université Paris VII Faculté de Médecine D. Diderot, Paris, France (C. Paugam-Burtz, F. Durand, J. Belghiti, M.H. Nicolas-Chanoine); INSERM U 773 Centre de Recherche Biomédicale Bichat-Beaujon, CRB3, Paris (F. Durand, R. Moreau, M.H. Nicolas-Chanoine)

Main Article

Table 3

Antimicrobial drug susceptibility, ERIC-2 PCR type, and β-lactamase gene content of the 39 clinical isolates of ESBL-producing Enterobacteriaceae identified, France, January 2001–April 2010*

Species Year of isolation Susceptibility
ERIC-2 PCR type β-lactamase types†
TZP FOX AMK CIP CTX-M-1 group CTX-M-9 group ESBL TEM Non-ESBL TEM ESBL SHV Non-ESBL SHV
E. coli 2003 S S S R 1 + +
E. coli 2004 R S S R 2 + +
E. coli 2004 R R S S 3 +
E. coli 2007 R R R R 4 +
E. coli 2007 S S S R 5 + + +
E. coli 2008 S S R R 6 +
E. coli 2008 R S S R 7 +
E. coli 2008 S S S S 8 + + +
E. coli 2009 S S R R 9 + +
E. coli 2009 S S S R 10 +
E. coli 2009 S R R R 9 + +
E. coli 2009 R S R R 11 + + +
E. coli 2009 R S S R 4 + +
E. coli 2010 R S R R 12 +
E. coli 2010 S S S S 13 +
E. coli 2010 R R R R 14 +
K. pneumoniae 2008 R S S R 15 + +
K. pneumoniae 2008 R S S R 16 + +
K. pneumoniae 2010 R R R R 17 + + +
K. pneumoniae 2010 R R R R 17 + + +
K. pneumoniae 2010 R S S R 15 + +
K. oxytoca 2009 R R R R 18 +
K. oxytoca 2009 R R R R 18 +
K. oxytoca 2009 R R R R 18 + +
C. koserii 2006 S R R R 19 + +
C. koserii 2006 S R R R 19 + +
E. cloacae 2002 R R R R 20 + -
E. cloacae 2004 R R R R 21 + + +
E. cloacae 2004 R R S R 22 +
E. cloacae 2004 R R I R 23 +
E. cloacae 2005 R R R R 24 +
E. cloacae 2008 S R R R 25 + + +
E. cloacae 2008 S R R R 21 + +
E. cloacae 2009 R R S R 26 + +
E. cloacae 2009 R R S R 27 +
E. cloacae 2009 S R R R 28 + +
E. cloacae 2010 S R R R 29 + +
E. aerogenes 2002 R R R R 30 + +
E. aerogenes 2005 R R R R 31 + + + +

*ERIC-2, enterobacterial repetitive intergenic consensus sequence type 2; ESBL, extended-spectrum β-lactamase; TZP, piperacillin/tazobactam; FOX, cefoxitin; AMK, amikacin; CIP, ciprofloxacin; E. coli, Escherichia coli; S, susceptible; R, resistant; K. pneumoniae, Klebsiella pneumoniae; K. oxytoca, Klebsiella oxytoca; C. koserii, Citrobacter koserii; E. cloacae, Enterobacter cloacae; E. aerogenes, Enterobacter aerogenes.
†The types of β-lactamase were identified by the Check-KPC ESBL microarray system (Check-Points, Wageningen, the Netherlands).

Main Article

Page created: May 17, 2012
Page updated: May 17, 2012
Page reviewed: May 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external